Rankings
▼
Calendar
AUPH Q3 2016 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31,000
Gross Profit
$30,000
96.8% margin
Operating Income
-$5M
-17387.1% margin
Net Income
-$7M
-23932.3% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
-43.6%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$548,000
Balance Sheet
Total Assets
$33M
Total Liabilities
$13M
Stockholders' Equity
$20M
Cash & Equivalents
$12M
← FY 2016
All Quarters
Q4 2016 →
